CIK 0002139097 · <br>Emerging growth company
TRex Bio, Inc.
Sign in to watch- Ticker
- TRXB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- other
- Phone
- (650) 567-5582
- Business address
- C/O TREX BIO, INC., 269 EAST GRAND AVENUE SUITE 300, SOUTH SAN FRANCISCO, CA
- Open-market buys, last 90 days
- $3,799,992
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$3,799,992. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-08 | Ross Michael Jay Director | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2026-10-08 | Hirth Peter Director | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2026-10-08 | Gallagher Carol Giltner Director | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2026-10-08 | Gilmore Julie Ann Director | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 |
Page 2 of 2 · 24 trades